FOXM1688-748结构域相互作用蛋白的鉴定

为了鉴定转录因子FOXM1转录激活结构域(C-端第688位到748位氨基酸序列)的互作蛋白,以FOXM1的cDNA为模板,采用聚合酶链式反应(Polymerase Chain Reaction,PCR)方法扩增获得其转录激活结构域序列,克隆进入原核表达载体pGEX-4T2;利用大肠杆菌原核表达获得融合谷胱甘肽S-转移酶(Glutathione S-Transferase,GST)标签的重组蛋白GST-FOXM1688-748;通过GST-pulldown结合质谱方法鉴定FOXM1688-748的互作蛋白,成功构建了原核表达质粒pGEX-4T2-FOXM1688-748,获得了原核表达的重组蛋白GST-FOXM1688-748.将质谱鉴定获得的互作蛋白进行分析和归类,预示一些互作蛋白可以参与激活FOXM1的转录活性,如RPN2、MISP、MCM7蛋白,一些互作蛋白可以参与调控FOXM1蛋白的稳定性,如USP9Y、CUL4A、HSPB1、BAG2蛋白.FOXM1蛋白的转录激活结构域与许多不同功能的蛋白发生相互作用,暗示该结构域具有重要的分子生物学作用,期望为以FOXM1为靶点的临床药物研发提供实验依据.     

Rho信号通路抑制剂Y27632抑制TGF-β诱导的MCF-7细胞上皮间质转化

许多研究表明在乳腺癌的发生过程中上皮间质转化(epithelial-to-mesenchymal transition,EMT)起到十分重要的作用,转化生长因子–β(transforming growth factor-β,TGF-β)是公认的可以引起EMT的重要因子,在EMT过程中涉及许多信号通路,但是Rho信号通路在其中的作用尚未报道.本文首先建立TGF-β诱导人乳腺癌细胞MCF-7上皮间质转化的模型,利用划痕实验检测细胞迁移能力,利用实时定量荧光PCR(real-time PCR)和免疫印迹(Western blot)实验检测间质标志基因的表达情况.进一步通过加入Rho通路抑制剂Y27632研究Rho通路在TGF-β诱导的MCF-7细胞EMT中的作用,结果证实TGF-β可以诱导MCF-7细胞EMT,促进MCF-7细胞迁移,而Y27632抑制TGF-β诱导的MCF-7细胞EMT过程及其迁移.     

TGF-β1与EGF对肺泡Ⅱ型上皮细胞表型及功能的影响

目的:探讨TGF-β1与EGF对肺泡Ⅱ型上皮细胞(RLE-6TN)的影响。方法:将细胞分成对照(C)、TGF-β1(T)、EGF(E)及TGF-β1+EGF(TE)组。采用相差显微镜观察细胞形态,免疫荧光检测α-SMA表达,W.B检测上皮、间质细胞标记物、MMPs及信号蛋白的表达;流式细胞术检测凋亡情况。结果:T及TE组RLE-6TN发生EMT转变并见间质标记物及MT1-MMP、MMP2表达上调,E组Vimentin、MT1-MMP、MMP2及CD147表达上调;T与E组p-ERK、p-38MAPK及p-Akt表达上调,T组p-Smad2表达上调;T与E组均见凋亡,TE组凋亡加剧。结论:单用EGF不能诱导RLE-6TN发生EMT,合用TGF-β1无协同诱导EMT,却能协同诱导凋亡。TGF-β1诱导EMT时,主要通过EGFR信号通路诱导MMPs表达。     

PPM1A抑制胰腺癌细胞PANC-1的迁移侵袭和EMT进程

为研究镁依赖性蛋白磷酸酶1A(protein phosphatase magnesium-dependent 1A,PPM1A)对胰腺癌细胞迁移、侵袭及上皮-间充质转化(epithelial-mesenchymal transformation, EMT)的影响,采用生物信息学技术以及细胞免疫荧光实验分析PPM1A在胰腺癌中的表达情况,划痕、Transwell、qRT-PCR、Western blot、细胞免疫荧光实验检测PPM1A对胰腺癌细胞PANC-1迁移、侵袭及EMT标志物表达水平的影响,生物信息学网站预测PPM1A的上游miRNA.结果表明,PPM1A在胰腺癌中低表达,抑制PANC-1细胞的迁移、侵袭和EMT进程,miR-105-5p为PPM1A的潜在上游miRNA.说明PPM1A和miR-105-5p可能是治疗胰腺癌新的靶点.     

Construction of Eukaryotic Expression Vector of Human PSF and Identification of its Expression in CHO Cell Line

目的是构建人PSF基因真核表达载体pEGFP-N1-PSF,并在检测其在CHO细胞株中的表达情况.应用DNA重组技术和PCR方法从人宫颈癌Hela细胞中扩增PSF基因,插入pEGFPNL真核表达载体,构建重组质粒pEGFP-N1-PSF并测序鉴定.将pEGFP-N1-PSF瞬时转染CHO细胞,通过Western blot和RT-PCR方法检测PSF的表达,荧光显微镜下观察绿色荧光蛋白表达.结果CHO细胞转染pEGFP-N1-PSF真核表达载体后,RT-PCR和Western blot实验发现,在RNA和蛋白水平有PSF的表达,在荧光显微镜下可以观察到融合蛋白EGFP/PSF的表达.成功构建pEGFP-N1-PSF真核表达载体,证实其在CHO细胞中可以表达.     

MiR-17促进胃癌细胞上皮间质转化机制

目的 探讨miR-17调控胃癌细胞上皮间质转化的作用机制.方法 检测胃癌组织和胃癌细胞系中miR-17的表达水平;分别将miR-17模拟物(抑制物)和TGFBR2过表达载体(siRNA)转染到SGC-7901胃癌细胞中,通过MTT法、流式细胞术、Transwell实验和Western blotting检测细胞增殖、凋亡、侵袭和EMT标志蛋白表达;荧光素酶报告基因分析验证miR-17与TGFBR2的靶向关系.结果 胃癌组织和胃癌细胞系中miR-17表达上调;过表达miR-17促进SGC-7901细胞增殖、侵袭,抑制凋亡;miR-17靶向TGFBR2的3'UTR;过表达TGFBR2抑制SGC-7901细胞增殖、侵袭,促进凋亡;miR-17通过激活PTEN/PI3K/AKT信号通路促进SGC-7901细胞EMT.结论 miR-17靶向下调TGFBR2表达,激活PTEN/PDK/AKT信号通路,促进SGC-7901细胞EMT.体内研究结果证明miR-17促进肿瘤的生长.因此,miR-17可能是胃癌抗转移治疗的潜在策略.     

HDAC1 siRNA对TGF-β1诱导的肺泡Ⅱ型上皮细胞EMT的影响

目的:探讨HDAC1 si RNA对TGF-β1诱导的RLE-6TN细胞EMT过程中细胞表型、功能的影响。方法:加入HDAC1 si RNA转染RLE-6TN后,再加TGF-β1后收取细胞。采用倒置显微镜观察各组细胞形态改变,免疫荧光检测表型改变,W.B及实时定量PCR检测其HDAC1、8,E-cad及α-SMA的表达;Transwell小室检测细胞体外迁移能力。结果:形态学上,TGF-β1能诱导RLE-6TN发生EMT,转染后细胞多边形、铺路石状;荧光显微镜下,TGF-β1组出现α-SMA表达,HDAC1表达增加,转染组相反;在m RNA水平,TGF-β1组E-cad表达下调、HDAC1、8上调,转染组HDAC1、8表达下调,α-SMA上调。在蛋白水平,TGF-β1组E-cad表达下调、α-SMA及HDAC1上调,转染组相反。体外迁移能力方面,TGF-β1组迁移细胞增多、转染组减少。结论:HDAC1 si RNA能部分逆转TGF-β1诱导的肺泡Ⅱ型上皮EMT。     

茶硝香酰胺联合吉非替尼对人非小细胞肺癌迁移的影响

本实验旨在探究茶氨酸衍生物茶硝香酰胺(TNC)和吉非替尼联合是否增强吉非替尼对人非小细胞肺癌A549细胞迁移的影响与其可能作用的分子机制,为抑制肺癌远处转移和减少吉非替尼毒副作用提供新思路.采用细胞划痕术检测联合用药前后细胞迁移能力变化;上皮-间质转化(EMT)诱导实验结合Transwell实验观察发生EMT后A549迁移能力改变;蛋白免疫印迹法检测相关蛋白的表达.结果显示:TNC联合吉非替尼可显著抑制A549细胞迁移,且间质标志物N-Cadherin、Vimentin显著下调,上皮细胞标志物E-Cadherin明显上调,与迁移相关转录抑制因子ZEB、Slug、Snail、Twist表达显著下降,同时AKT、NF-κB等蛋白表达水平下调.提示TNC联合吉非替尼可能是通过抑制A549细胞的EMT过程从而增强吉非替尼对A549细胞迁移的抑制作用.     

PinX1基因真核表达载体的构建及其对乳腺癌MCF-7细胞增殖的抑制作用

探讨了PinX1 基因在乳腺癌MCF-7 细胞生长和细胞周期中的作用, 初步探讨了该基因用于乳腺癌临床治疗的可行性. 采用RT-PCR 技术从293-T 细胞中扩增PinX1 基因, 将其克隆入真核表达载体pEGFP-C1 中, 再将重组质粒转染MCF-7 细胞. 通过real-time PCR 检测PinX1 基因的mRNA 表达, 用MTT 法检测转染前后细胞生长曲线的变化, 用流式细胞仪检测转染目的基因后细胞生长周期的改变. 检测结果表明, PinX1 基因已经在转染后MCF-7 细胞的细胞核内稳定表达, 乳腺癌细胞生长明显减缓(P <0.05), 增殖变慢(P <0.05), 细胞生长阻滞于G0/G1 期, 说明PinX1 基因可抑制乳腺癌MCF-7 细胞的生长和增殖.     

Nicotine-induced upregulation of antioxidant protein Prx 1 in oral squamous cell carcinoma

Nicotine is a source of exogenous oxidative stress, which is associated with the pathogenesis of numerous diseases including oral squamous cell carcinoma (OSCC), whereas an antioxidant protein, peroxiredoxin 1 (Prx 1), plays an important role in the modulation of this condition. This study was to investigate the association between Prx 1 and tobacco-induced oxidative stress. The expression of Prx 1 and GST in OSCC Tca8113 cells, which were pre-treated with nicotine, was determined. In the present study, MTT assay, reactive oxygen species (ROS) assay, RT-PCR and Western blot analyses, respectively, were conducted to assess cell viability, ROS level, and expression level of Prx 1 and GST in nicotine-treated Tca8113 cells. Nuclear factor kappa B (NF- B) expression was detected by immuno-fluorescence. Our results showed the growth of Tca8113 cells was increased in a dose-dependent manner when cells were treated with nicotine at concentrations from 0.1 to 10 mol/L, but the proliferation of the cells decreased at 100 mol/L. ROS levels increased in all groups treated with nicotine at concentrations of 0.1, 1, 10, or 100 mol/L for 24h. Prx 1 and GST mRNA and protein expression were up-regulated in cells treated with nicotine for the same time at different concentrations or at the same concentration for different times (P<0.05). NF-B was translocated from cytoplasm to nucleus, the expression of NF- B was increased in nucleus. These results suggest that up-regulation of Prx1 expression appears to be associated with tobacco-induced oxidative stress, which may play an important role in the pathogenesis of OSCC.     

VEGF165过表达对小鼠乳腺癌及肿瘤周边皮肤血管生成模式的影响研究

已证实乳腺癌细胞表达有VEGF165的第3个受体NRP1,但目前在乳腺癌细胞中过表达VEGF165对肿瘤周围血管生成模式的影响尚未有人研究.通过脂质体转染的方法得到稳定转染过表达VEGF165的细胞克隆,皮内接种研究其对周围皮肤生血管模式的影响.结果显示VEGF165在乳腺癌中过表达可使肿瘤周围皮肤产生树状血管生成模式,且会诱导不成熟的血管生成并致出血.稳定过表达VEGF165的乳腺癌克隆的建立,为进一步研究过表达VEGF165对乳腺癌的影响奠定了基础.     

威廉环毛蚓Pheretima guillelmi(Michaelsen)神经内分泌系统的研究

以威廉环毛蚓为实验材料,对其神经内分泌系统的显微、亚显微结构及其对体表水交换的影响作了初步研究.通过大量的实验,说明在威廉环毛蚓的中枢神经系统中存在三种不同类型的细胞,即A、B和C三种细胞.A细胞数量最多,位于脑神经节、咽下神经节和腹神经索中.B细胞主要位于咽下神经节.C细胞主要位于咽下神经节和腹神经索中.神经内分泌活动与季节有关,A细胞和C细胞的分泌活动随季节变化而不同,B细胞的内分泌活动受季节的影响不大.蚯蚓体表的水交换受神经内分泌调控,这种因子仅存在于脑神经节内.     

A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm

Oestrogen receptor (ER) is a good prognostic marker for the treatment of breast cancers. Upregulation of metastatic tumour antigen 1 (MTA1) is associated with the invasiveness and metastatic potential of several human cancers and acts as a co-repressor of nuclear ER-alpha. Here we identify a naturally occurring short form of MTA1 (MTA1s) that contains a previously unknown sequence of 33 amino acids with an ER-binding motif, Leu-Arg-Ile-Leu-Leu (LRILL). MTA1s localizes in the cytoplasm, sequesters ER in the cytoplasm, and enhances non-genomic responses of ER. Deleting the LRILL motif in MTA1s abolishes its co-repressor function and its interaction with ER, and restores nuclear localization of ER. Dysregulation of human epidermal growth factor receptor-2 in breast cancer cells enhances the expression of MTA1s and the cytoplasmic sequestration of ER. Expression of MTA1s in breast cancer cells prevents ligand-induced nuclear translocation of ER and stimulates malignant phenotypes. MTA1s expression is increased in human breast tumours with no or low nuclear ER. The regulation of the cellular localization of ER by MTA1s represents a mechanism for redirecting nuclear receptor signalling by nuclear exclusion.     

注射麻醉剂抑制小鼠EMT6乳腺肿瘤的生长

通过注射常规麻醉剂,可以降低患肿瘤生物个体新陈代谢强度,继而抑制其肿瘤生长及降低疼痛;观察了麻醉剂对移植性小鼠乳腺癌(EMT6)生长的抑制作用。通过对移植乳腺癌肿瘤小鼠的培养及给药实验,全面模拟人体生长肿瘤时的生理特征。在小鼠完成移植肿瘤细胞1周后,开始注射麻醉剂,同时对肿瘤生长及小鼠生理状况进行逐天监控;给药2周后处死小鼠并检测。实验发现,注射麻醉剂组小鼠肿瘤生长速度慢于实验对照组,肿瘤抑制率最高达18.5%。结果表明,注射麻醉剂可以延缓肿瘤生长,在乳腺癌治疗上具有可行性。     

氯化1-辛基-3-甲基咪唑对EMT6细胞的毒性及其DNA损伤作用

研究了氯化1-辛基-3-甲基咪唑([C8mim][Cl])对EMT6细胞的毒性大小及其可能的遗传机制.不同浓度(0.06、0.25、1.00mmol·L-1)的[C8mim][Cl]对EMT6细胞染毒12h,WST-1比色法检测了细胞活力,ELISA方法检测了Bcl-2蛋白的表达,Hoechst 33342染色检测了细胞核形态的变化,单细胞凝胶电泳(SCGE)检测了细胞DNA的损伤,流式细胞仪检测了细胞周期和细胞DNA的含量.结果显示,经[C8mim][Cl]染毒后,EMT6细胞活力下降,并且呈剂量依赖关系.当[C8mim][Cl]浓度高于0.25mmol·L-1时,与对照相比,差异显著.[C8mim][Cl]染毒使Bcl-2蛋白表达下调,引起了细胞核形态改变,造成了DNA的断裂损伤和含量下降,诱导了细胞凋亡.从而可以得出结论,DNA损伤参与了[C8mim][Cl]诱导的细胞凋亡.     

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.     

灯盏乙素对乳腺癌细胞中lncRNAs表达的影响

检测灯盏乙素对乳腺癌MDA-MB-231细胞中的长链非编码RNA(LncRNAs)的相对表达量的影响,进一步探索灯盏乙素对肿瘤的作用机制.采用实时荧光定量PCR的方法,检测对照组与不同剂量组的灯盏乙素处理后的乳腺肿瘤细胞中lncRNAs MALAT1、NEAT1和p53基因mRNA的相对表达量,并观察细胞存活率.结果发现,灯盏乙素在低剂量(1、10、25μmol/L)时促进细胞增殖,而在高剂量50μmol/L以上时抑制细胞增殖.灯盏乙素在低剂量时使得乳腺癌MDA-MB-231细胞中MALAT1,NEAT1和p53基因的表达水平下降,而在100μmol/L的高剂量时MALAT1,NEAT1和p53基因的表达水平上升.灯盏乙素影响乳腺癌MDA-MB-231细胞中LncRNAs MALAT1和NEAT1基因以及p53基因的表达,并且存在剂量反应关系,低剂量与高剂量呈现出相反的表达量变化.